These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22734967)

  • 1. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
    Yang YY; Huang YT; Tsai TH; Hou MC; Lee FY; Lee SD; Lin HC
    Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
    Yang YY; Tsai TH; Huang YT; Lee TY; Chan CC; Lee KC; Lin HC
    Hepatology; 2012 May; 55(5):1540-50. PubMed ID: 22183953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
    Graupera M; García-Pagán JC; Abraldes JG; Peralta C; Bragulat M; Corominola H; Bosch J; Rodés J
    Hepatology; 2003 Jan; 37(1):172-81. PubMed ID: 12500202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2).
    El-Badry AM; Jang JH; Elsherbiny A; Contaldo C; Tian Y; Raptis DA; Laczko E; Moritz W; Graf R; Clavien PA
    J Hepatol; 2011 Dec; 55(6):1291-9. PubMed ID: 21703192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.
    Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; García-Calderó H; Bosch J; García-Pagán JC
    J Hepatol; 2007 Aug; 47(2):220-7. PubMed ID: 17459512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).
    Steib CJ; Gerbes AL; Bystron M; Op den Winkel M; Härtl J; Roggel F; Prüfer T; Göke B; Bilzer M
    J Hepatol; 2007 Aug; 47(2):228-38. PubMed ID: 17573142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thromboxane A2 in early BDL-induced portal hypertension.
    Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
    Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
    Graupera M; March S; Engel P; Rodés J; Bosch J; García-Pagán JC
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G763-70. PubMed ID: 15550559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adipocytokines in hepatic fibrogenesis.
    Ikejima K; Okumura K; Kon K; Takei Y; Sato N
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S87-92. PubMed ID: 17567476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
    Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
    Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels.
    García-Redondo AB; Briones AM; Beltrán AE; Alonso MJ; Simonsen U; Salaices M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):19-27. PubMed ID: 18818375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride reduces portal hypertension in rat liver cirrhosis.
    Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
    Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased intrahepatic response to alpha(1)-adrenergic agonists in lipopolysaccharide-treated rats is located in the sinusoidal area and depends on Kupffer cell function.
    Lee CH; Loureiro-Silva MR; Abraldes JG; Iwakiri Y; Haq O; Groszmann RJ
    J Gastroenterol Hepatol; 2007 Jun; 22(6):893-900. PubMed ID: 17498219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.
    Yang YY; Lee PC; Huang YT; Lee WP; Kuo YJ; Lee KC; Hsieh YC; Lee TY; Lin HC
    Clin Sci (Lond); 2014 Jan; 126(2):163-74. PubMed ID: 23875703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.
    Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.